Home › Triple-Negative Breast Cancer › Illinois › Carbondale
Triple-Negative Breast Cancer clinical trials in Carbondale, IL
3 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Carbondale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RecruitingPhase 3
- Southern Illinois Hospital Services ( Site 9554), Carterville · 8 mi away
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
RecruitingPhase 3
- Southern Illinois Hospital Services ( Site 9547), Carterville · 8 mi away
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
RecruitingObservational study
- Southern Illinois Hospital Services, Carbondale
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY33 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA24 studies
- San Antonio, TX24 studies
- Arlington, VA21 studies
- St. Louis, MO21 studies
- Atlanta, GA19 studies
- Dallas, TX18 studies
- New Haven, CT16 studies
- Grand Rapids, MI16 studies
Other studies in Carbondale
- Breast Cancer7 studies
- Colorectal Cancer7 studies
- Non-Small Cell Lung Cancer5 studies
- Lung Cancer4 studies
- Colon Cancer4 studies
- Cancer (all types)3 studies
- Pancreatic Cancer3 studies
- Prostate Cancer3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Melanoma3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.